Abstract
Corneal trauma/injury often results in serious complications including permanent vision loss or loss of visual acuity which demands corneal transplantations or treatment with allogenic graft tissues. There is currently a huge shortage of donor tissue worldwide and the need for human corneal equivalents increases annually. In order to meet such demand the current clinical approach of treating corneal injuries is limited and involves synthetic and allogenic materials which have various shortcomings when it comes to actual transplantations. In this study we introduce the newly developed, next generation of our previously established 3D self-assembled constructs, where multiple constructs are grown and stacked on top of each other without any other artificial product. This new technology brings our 3D in vitro model closer to what is seen in vivo and provides a solid foundation for future studies on corneal biology.
Lipids are known for playing a vital role during metabolism and diseased state of various tissues and Sphingolipids are one such class of lipids which are involved in various cellular mechanisms and signaling processes. The impacts of Sphingolipids that have been documented in several human diseases often involve inflammation, neovascularization, tumorigenesis, and diabetes, but these conditions are not yet thoroughly studied. There is very little information about the exact role of Sphingolipids in the human cornea and future studies aiming at dissecting the mechanisms and pathways involved in order to develop novel therapies. We believe that our novel 3D stacked model can be used to delineate the role of Sphingolipids in the human cornea and provide new insights for understanding and treating various human corneal diseases.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Akpek EK, Alkharashi M, Hwang FS, Ng SM, Lindsley K (2014) Artificial corneas versus donor corneas for repeat corneal transplants. Cochrane Database Syst Rev CD009561
Chen FM, Liu X (2016) Advancing biomaterials of human origin for tissue engineering. Prog Polym Sci 53:86–168
Karamichos D, Brown RA, Mudera V (2007) Collagen stiffness regulates cellular contraction and matrix remodeling gene expression. J Biomed Mater Res A 83:887–894
Griffith LG, Naughton G (2002) Tissue engineering—current challenges and expanding opportunities. Science 295:1009–1014
Ruberti JW, Zieske JD (2008) Prelude to corneal tissue engineering—gaining control of collagen organization. Prog Retin Eye Res 27:549–577
Guo X, Hutcheon AE, Melotti SA, Zieske JD, Trinkaus-Randall V et al (2007) Morphologic characterization of organized extracellular matrix deposition by ascorbic acid-stimulated human corneal fibroblasts. Invest Ophthalmol Vis Sci 48:4050–4060
Karamichos D (2015) Ocular tissue engineering: current and future directions. J Funct Biomater 6:77–80
Zieske JD (2001) Extracellular matrix and wound healing. Curr Opin Ophthalmol 12:237–241
Karamichos D, Guo XQ, Hutcheon AE, Zieske JD (2010) Human corneal fibrosis: an in vitro model. Invest Ophthalmol Vis Sci 51:1382–1388
Priyadarsini S, Sarker-Nag A, Rowsey TG, Ma JX, Karamichos D (2016) Establishment of a 3D in vitro model to accelerate the development of human therapies against corneal diabetes. PLoS One 11:e0168845
Karamichos D, Hjortdal J (2014) Keratoconus: tissue engineering and biomaterials. J Funct Biomater 5:111–134
Wilson SL, Yang Y, el Haj AJ (2014) Corneal stromal cell plasticity: in vitro regulation of cell phenotype through cell-cell interactions in a three-dimensional model. Tissue Eng A 20:225–238
Proulx S, Uwamaliya JD, Carrier P, Deschambeault A, Audet C et al (2010) Reconstruction of a human cornea by the self-assembly approach of tissue engineering using the three native cell types. Mol Vis 16:2192–2201
Gonzalez-Andrades M, Alonso-Pastor L, Mauris J, Cruzat A, Dohlman CH et al (2016) Establishment of a novel in vitro model of stratified epithelial wound healing with barrier function. Sci Rep 6:19395
Hopkins AM, DeSimone E, Chwalek K, Kaplan DL (2015) 3D in vitro modeling of the central nervous system. Prog Neurobiol 125:1–25
Schulz S, Beck D, Laird D, Steinberg T, Tomakidi P et al (2014) Natural corneal cell-based microenvironment as prerequisite for balanced 3D corneal epithelial morphogenesis: a promising animal experiment-abandoning tool in ophthalmology. Tissue Eng Part C Meth 20:297–307
Ghezzi CE, Rnjak-Kovacina J, Kaplan DL (2015) Corneal tissue engineering: recent advances and future perspectives. Tissue Eng Part B Rev 21:278–287
Karamichos D, Hutcheon AE, Zieske JD (2011) Transforming growth factor-beta3 regulates assembly of a non-fibrotic matrix in a 3D corneal model. J Tissue Eng Regen Med 5:e228–e238
Karamichos D, Lakshman N, Petroll WM (2009) An experimental model for assessing fibroblast migration in 3-D collagen matrices. Cell Motil Cytoskeleton 66:1–9
Karamichos D, Zareian R, Guo X, Hutcheon AE, Ruberti JW et al (2012) Novel in vitro model for Keratoconus disease. J Funct Biomater 3:760–775
Karamichos D, Rich CB, Zareian R, Hutcheon AE, Ruberti JW et al (2013) TGF-β3 stimulates stromal matrix assembly by human corneal keratocyte-like cells. Invest Ophthalmol Vis Sci 54:6612–6619
Karamichos D, Hutcheon AE, Zieske JD (2014) Reversal of fibrosis by TGF-beta3 in a 3D in vitro model. Exp Eye Res 124:31–36
Saika S (2006) TGFbeta pathobiology in the eye. Lab Invest 86:106–115
Coant N, Sakamoto W, Mao C, Hannun YA (2016) Ceramidases, roles in sphingolipid metabolism and in health and disease. Adv Biol Regul 63:122–131
Brush RS, Tran JT, Henry KR, McClellan ME, Elliott MH et al (2010) Retinal sphingolipids and their very-long-chain fatty acid-containing species. Invest Ophthalmol Vis Sci 51:4422–4431
Shea BS, Brooks SF, Fontaine BA, Chun J, Luster AD et al (2010) Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury. Am J Respir Cell Mol Biol 43:662–673
Shea BS, Tager AM (2012) Sphingolipid regulation of tissue fibrosis. Open Rheumatol J 6:123–129
Swaney JS, Moreno KM, Gentile AM, Sabbadini RA, Stoller GL (2008) Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye. Exp Eye Res 87:367–375
Watsky MA, Weber KT, Sun Y, Postlethwaite A (2010) New insights into the mechanism of fibroblast to myofibroblast transformation and associated pathologies. Int Rev Cell Mol Biol 282:165–192
Priyadarsini S, McKay TB, Sarker-Nag A, Allegood J, Chalfant C et al (2016) Complete metabolome and lipidome analysis reveals novel biomarkers in the human diabetic corneal stroma. Exp Eye Res 153:90–100
French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN et al (2003) Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 63:5962–5969
Acknowledgement
This work was supported by NIH/NEI EY025256.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Priyadarsini, S., Nicholas, S.E., Karamichos, D. (2017). 3D Stacked Construct: A Novel Substitute for Corneal Tissue Engineering. In: Pébay, A., Turksen, K. (eds) Sphingosine-1-Phosphate. Methods in Molecular Biology, vol 1697. Humana Press, New York, NY. https://doi.org/10.1007/7651_2017_23
Download citation
DOI: https://doi.org/10.1007/7651_2017_23
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7412-2
Online ISBN: 978-1-4939-7413-9
eBook Packages: Springer Protocols